Murdoch I A, Beattie R M, Silver D M
Department of Paediatrics, Guy's Hospital, London, UK.
Acta Paediatr. 1993 May;82(5):495-7. doi: 10.1111/j.1651-2227.1993.tb12732.x.
Two children aged 3 months and 14 years developed heparin-induced thrombocytopenia whilst receiving heparin. The clinical course was complicated by renal vein thrombosis in the 3-month-old infant and subcutaneous haemorrhage requiring resuscitation in the 14-year-old child. Anticoagulant therapy was discontinued immediately in the 3-month-old child. In the 14-year-old child, because of the need for continued anticoagulation therapy, low molecular weight heparin was used until warfarin could be substituted.
两名分别为3个月大及14岁的儿童在接受肝素治疗时发生了肝素诱导的血小板减少症。临床过程中,3个月大的婴儿并发肾静脉血栓形成,14岁的儿童出现皮下出血,需要进行复苏。3个月大的儿童立即停用抗凝治疗。在14岁的儿童中,由于需要继续抗凝治疗,在华法林可以替代之前使用了低分子量肝素。